These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33374979)

  • 21. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
    Kundu P; Mohanty C; Sahoo SK
    Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative Delivery Systems for Curcumin: Exploring Nanosized and Conventional Formulations.
    Yakubu J; Pandey AV
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders.
    Moradi SZ; Momtaz S; Bayrami Z; Farzaei MH; Abdollahi M
    Front Bioeng Biotechnol; 2020; 8():238. PubMed ID: 32318551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic nanoplatforms and delivery strategies for neurological disorders.
    Kang YJ; Cutler EG; Cho H
    Nano Converg; 2018 Nov; 5(1):35. PubMed ID: 30499047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
    Mohanty C; Das M; Sahoo SK
    Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin as a potential therapeutic agent for treating neurodegenerative diseases.
    Perales-Salinas V; Purushotham SS; Buskila Y
    Neurochem Int; 2024 Jun; 178():105790. PubMed ID: 38852825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - Impact on bioavailability.
    Hagl S; Kocher A; Schiborr C; Kolesova N; Frank J; Eckert GP
    Neurochem Int; 2015 Oct; 89():234-42. PubMed ID: 26254982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
    Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
    Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
    Ma Z; Wang N; He H; Tang X
    J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the Antiproliferative Effects of Curcumin and Nanocurcumin in MDA-MB231 as a Breast Cancer Cell Line.
    Khosropanah MH; Dinarvand A; Nezhadhosseini A; Haghighi A; Hashemi S; Nirouzad F; Khatamsaz S; Entezari M; Hashemi M; Dehghani H
    Iran J Pharm Res; 2016; 15(1):231-9. PubMed ID: 27610163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives.
    Sharifi S; Fathi N; Memar MY; Hosseiniyan Khatibi SM; Khalilov R; Negahdari R; Zununi Vahed S; Maleki Dizaj S
    Phytother Res; 2020 Aug; 34(8):1926-1946. PubMed ID: 32166813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.
    Bisht S; Feldmann G; Soni S; Ravi R; Karikar C; Maitra A; Maitra A
    J Nanobiotechnology; 2007 Apr; 5():3. PubMed ID: 17439648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases.
    Salehi B; Del Prado-Audelo ML; Cortés H; Leyva-Gómez G; Stojanović-Radić Z; Singh YD; Patra JK; Das G; Martins N; Martorell M; Sharifi-Rad M; Cho WC; Sharifi-Rad J
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32164244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of Functional Biocompatible Nanomaterials to Improve Curcumin Bioavailability.
    Li Z; Shi M; Li N; Xu R
    Front Chem; 2020; 8():589957. PubMed ID: 33134284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
    Baek JS; Cho CW
    Eur J Pharm Biopharm; 2017 Aug; 117():132-140. PubMed ID: 28412471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases.
    Salehi B; Calina D; Docea AO; Koirala N; Aryal S; Lombardo D; Pasqua L; Taheri Y; Marina Salgado Castillo C; Martorell M; Martins N; Iriti M; Suleria HAR; Sharifi-Rad J
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32033365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
    Kundu P; Das M; Tripathy K; Sahoo SK
    ACS Chem Neurosci; 2016 Dec; 7(12):1658-1670. PubMed ID: 27642670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs.
    Naqvi S; Panghal A; Flora SJS
    Front Neurosci; 2020; 14():494. PubMed ID: 32581676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral bioavailability of curcumin: problems and advancements.
    Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
    J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.